Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence
R Harding, D Karus, P Easterbrook… - Sexually transmitted …, 2005 - sti.bmj.com
Background: The need for palliative care in HIV management is underlined by the high
prevalence of pain and symptoms, the toxicity, side effects, and virological failure associated …
prevalence of pain and symptoms, the toxicity, side effects, and virological failure associated …
The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models
The US Government has pledged to spend $15 billion in Africa and the Caribbean on AIDS.
A central focus of this plan is to provide antiretroviral treatment (ART) to millions. Here, we …
A central focus of this plan is to provide antiretroviral treatment (ART) to millions. Here, we …
[KIRJA][B] Handbook of health psychology
A Baum, TA Revenson, J Singer - 2012 - taylorfrancis.com
Considered the most comprehensive handbook in the field, this rich resource reviews the
biological, psychological, and social factors that affect health, health behavior, and illness …
biological, psychological, and social factors that affect health, health behavior, and illness …
Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral …
MH Antoni, AW Carrico, RE Durán… - Psychosomatic …, 2006 - journals.lww.com
Objective: Human Immunodeficiency Virus (HIV)–positive individuals treated with highly
active antiretroviral therapy (HAART) may experience psychological burdens and negative …
active antiretroviral therapy (HAART) may experience psychological burdens and negative …
Costs and benefits of multiple resistance to insecticides for Culex quinquefasciatus mosquitoes
C Berticat, J Bonnet, S Duchon, P Agnew… - BMC evolutionary …, 2008 - Springer
Background The evolutionary dynamics of xenobiotic resistance depends on how resistance
mutations influence the fitness of their bearers, both in the presence and absence of …
mutations influence the fitness of their bearers, both in the presence and absence of …
Reductions in depressed mood and denial co** during cognitive behavioral stress management with HIV-positive gay men treated with HAART
AW Carrico, MH Antoni, RE Durán… - Annals of Behavioral …, 2006 - academic.oup.com
Background: Stress management interventions for HIV-positive persons have been
designed to enhance co** skills and encourage health-promoting behaviors with the hope …
designed to enhance co** skills and encourage health-promoting behaviors with the hope …
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice
UK Collaborative Group on HIV Drug Resistance… - Aids, 2005 - journals.lww.com
Background: Little is known about the long term risk of development of HIV-1 drug resistance
for patients starting antiretroviral therapy (ART) with three or four drug regimens in routine …
for patients starting antiretroviral therapy (ART) with three or four drug regimens in routine …
Current status of gene therapy strategies to treat HIV/AIDS
DS Strayer, R Akkina, BA Bunnell, B Dropulic… - Molecular therapy, 2005 - cell.com
Progress in develo** effective gene transfer approaches to treat HIV-1 infection has been
steady. Many different transgenes have been reported to inhibit HIV-1 in vitro. However …
steady. Many different transgenes have been reported to inhibit HIV-1 in vitro. However …
Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally …
T Cihlar, AS Ray, CG Boojamra, L Zhang… - Antimicrobial agents …, 2008 - Am Soc Microbiol
ABSTRACT GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2, 5-dihydro-furan-2-yloxymethyl)
phosphonic acid] is a novel ribose-modified human immunodeficiency virus type 1 (HIV-1) …
phosphonic acid] is a novel ribose-modified human immunodeficiency virus type 1 (HIV-1) …
HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time
J Ghosn, I Pellegrin, C Goujard, C Deveau, JP Viard… - Aids, 2006 - journals.lww.com
Objective: Characterization of the early establishment of the viral reservoir in patients
acquiring resistant strains at primary HIV-1 infection (PHI), and longitudinal analysis of …
acquiring resistant strains at primary HIV-1 infection (PHI), and longitudinal analysis of …